In last trading session, Viking Therapeutics Inc (NASDAQ:VKTX) saw 1.48 million shares changing hands with its beta currently measuring 1.00. Company’s recent per share price level of $65.80 trading at $1.19 or 1.83% at ring of the bell on the day assigns it a market valuation of $7.29B. That closing price of VKTX’s stock is at a discount of -51.08% from its 52-week high price of $99.41 and is indicating a premium of 87.42% from its 52-week low price of $8.28. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.22 million shares which gives us an average trading volume of 3.38 million if we extend that period to 3-months.

For Viking Therapeutics Inc (VKTX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.25 in the current quarter.

Viking Therapeutics Inc (NASDAQ:VKTX) trade information

Upright in the green during last session for gaining 1.83%, in the last five days VKTX remained trading in the red while hitting it’s week-highest on Tuesday, 10/15/24 when the stock touched $65.80 price level, adding 2.76% to its value on the day. Viking Therapeutics Inc’s shares saw a change of 253.57% in year-to-date performance and have moved -0.06% in past 5-day. Viking Therapeutics Inc (NASDAQ:VKTX) showed a performance of -3.46% in past 30-days. Number of shares sold short was 14.48 million shares which calculate 4.58 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 110.5 to the stock, which implies a rise of 40.45% to its current value. Analysts have been projecting 15 as a low price target for the stock while placing it at a high target of 138. It follows that stock’s current price would jump 77.2% in reaching the projected high whereas dropping to the targeted low would mean a gain of 77.2% for stock’s current value.

Viking Therapeutics Inc (VKTX) estimates and forecasts

Statistics highlight that Viking Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 3.75% of value to its shares in past 6 months, showing an annual growth rate of -9.89% while that of industry is 17.20. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -18.89% during past 5 years. In 2024, company’s earnings growth rate is likely to be around -9.61% while estimates for its earnings growth in next 5 years are of 40.00%.

Viking Therapeutics Inc (NASDAQ:VKTX)’s Major holders

Insiders are in possession of 6.03% of company’s total shares while institution are holding 75.38 percent of that, with stock having share float percentage of 80.22%. Investors also watch the number of corporate investors in a company very closely, which is 75.38% institutions for Viking Therapeutics Inc that are currently holding shares of the company. FMR LLC is the top institutional holder at VKTX for having 16.54 million shares of worth $876.8 million. And as of 2024-06-30, it was holding 15.9876 of the company’s outstanding shares.

The second largest institutional holder is VANGUARD GROUP INC, which was holding about 10.1 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.7599 of outstanding shares, having a total worth of $535.26 million.